Receiver operating curves and dose-volume analysis of late toxicity with stereotactic body radiation therapy for prostate cancer.

Journal: Practical radiation oncology
PMID:

Abstract

PURPOSE: The purpose of this study was to evaluate a receiver operating characteristic (ROC) curve method to determine dose thresholds with late genitourinary (GU) toxicity after stereotactic body radiation therapy for prostate cancer.

Authors

  • Li Zhang
    Department of Animal Nutrition and Feed Science, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, China.
  • Julian Johnson
    Department of Radiation Oncology, University of California at San Francisco, San Francisco, California.
  • Alexander R Gottschalk
    Department of Radiation Oncology, University of California at San Francisco, San Francisco, California.
  • Albert J Chang
    Department of Radiation Oncology, University of California at San Francisco, San Francisco, California.
  • I-Chow Hsu
    Department of Radiation Oncology, University of California at San Francisco, San Francisco, California.
  • Mack Roach
    Department of Radiation Oncology, University of California at San Francisco, San Francisco, California; Department of Urology, University of California at San Francisco, San Francisco, California.
  • Zachary A Seymour
    Department of Radiation Oncology, Oakland University William Beaumont School of Medicine, Beaumont Health System, Royal Oak, Michigan. Electronic address: zachary.seymour@beaumont.edu.